P/E ratio for Elevance Health (ELV)
P/E ratio as of May 2024 (TTM): 20.6
According to Elevance Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 20.5571. At the end of 2022 the company had a P/E ratio of 20.6.
P/E ratio history for Elevance Health from 2002 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 20.6 | 11.3% |
| 2021 | 18.5 | 4.83% |
| 2020 | 17.7 | 10.03% |
| 2019 | 16.1 | -11.07% |
| 2018 | 18.1 | 18.42% |
| 2017 | 15.2 | -0.4% |
| 2016 | 15.3 | 6.74% |
| 2015 | 14.3 | 6.96% |
| 2014 | 13.4 | 20.97% |
| 2013 | 11.1 | 51.06% |
| 2012 | 7.34 | -18.34% |
| 2011 | 8.99 | 12.09% |
| 2010 | 8.02 | 37.28% |
| 2009 | 5.84 | -33.61% |
| 2008 | 8.80 | -43.46% |
| 2007 | 15.6 | -2.55% |
| 2006 | 16.0 | -19.18% |
| 2005 | 19.8 | -10.35% |
| 2004 | 22.0 | 64.2% |
| 2003 | 13.4 | -2.31% |
| 2002 | 13.7 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.